Press Release

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences

Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease

ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting

Aspen Neuroscience: Study of ANPD001 Autologous Neuronal Cell Replacement Treatment Approach Published in Journal of Neurosurgery

Truvian Health raises $74M to bring blood testing to anyone, anywhere

SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment

ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association

Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting